1. Home
  2. MDRR vs TVGN Comparison

MDRR vs TVGN Comparison

Compare MDRR & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medalist Diversified REIT Inc.

MDRR

Medalist Diversified REIT Inc.

N/A

Current Price

$11.46

Market Cap

18.3M

Sector

Real Estate

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.58

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MDRR
TVGN
Founded
2015
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Blank Checks
Sector
Real Estate
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
21.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
MDRR
TVGN
Price
$11.46
$6.58
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
8.6K
10.9K
Earning Date
03-02-2026
05-13-2026
Dividend Yield
2.43%
N/A
EPS Growth
N/A
N/A
EPS
4.74
N/A
Revenue
$10,396,618.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.36
N/A
Revenue Growth
6.79
N/A
52 Week Low
$9.47
$0.14
52 Week High
$14.52
$12.03

Technical Indicators

Market Signals
Indicator
MDRR
TVGN
Relative Strength Index (RSI) 49.63 53.59
Support Level $11.09 $6.33
Resistance Level $12.08 $7.42
Average True Range (ATR) 0.21 0.69
MACD 0.02 0.15
Stochastic Oscillator 20.86 70.40

Price Performance

Historical Comparison
MDRR
TVGN

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: